Based on the strong effects of free NEMO (unbound to catalytic IKK subunits) on ALT levels, we further examined potential NEMO-specific effects on LPC cell death as a fundamental driver of liver diseases, and particularly HCC [12]. This evidence concerns the gene GPT and hepatocellular carcinoma.